8AIQ
Mpro of SARS COV-2 in complex with the MG-87 inhibitor
This is a non-PDB format compatible entry.
Summary for 8AIQ
Entry DOI | 10.2210/pdb8aiq/pdb |
Descriptor | Replicase polyprotein 1ab, ~{tert}-butyl ~{N}-[1-[(2~{S})-1-[[(2~{S},3~{R})-4-azanyl-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]butan-2-yl]amino]-3-cyclopropyl-1-oxidanylidene-propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate, CHLORIDE ION, ... (4 entities in total) |
Functional Keywords | inhibitor complex, sars-cov2, viral protein |
Biological source | Severe acute respiratory syndrome coronavirus |
Total number of polymer chains | 2 |
Total formula weight | 68697.67 |
Authors | El Kilani, H.,Hilgenfeld, R. (deposition date: 2022-07-27, release date: 2023-08-16, Last modification date: 2024-10-09) |
Primary citation | EL Kilani, H.,Hilgenfeld, R. Main Protease SARS-COV-2 in complex with the inhibitor MG-87 To Be Published, |
Experimental method | X-RAY DIFFRACTION (2.19 Å) |
Structure validation
Download full validation report